PDCD1 and neoplasm: In contrast, in the context of PD-1 blockade in the same tumour model, cDC1-derived IL-12 was necessary for an anti-tumour response31, suggesting distinct, potentially synergistic, therapeutic pathways mediated by different cDC subsets.